MYLAN NV ORDINARY SHARES (MYL) Covered Calls

MYLAN NV ORDINARY SHARES covered calls Mylan, Inc. and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients.

You can sell covered calls on MYLAN NV ORDINARY SHARES to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MYL (prices last updated Fri 4:16 PM ET):

MYLAN NV ORDINARY SHARES (MYL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
32.21 -0.21 32.00 32.89 5.5M 38 17B
Covered Calls For MYLAN NV ORDINARY SHARES (MYL)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 32.5 1.35 31.54 3.0% 37.8%
Jan 18 32.5 2.16 30.73 5.8% 23.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products. It operates through the following businesses: Generic Products, Rx Products, Active Pharmaceutical Ingredients, and Access Channels. The Generic Products business provides therapeutic categories, dosage forms and delivery system to help patients. The Rx Products business develops, manufacture and sells prescription medicines to help patients and physicians manage respiratory diseases, severe allergic reactions and psychiatric disorders. The Active Pharmaceutical Ingredients business produces API, the ingredients responsible for medicine's therapeutic effects, and antiretrovirals, the medicines for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). The Access Channels business provides access to medicines. The company was founded on July 7, 2014 and is headquartered in Potters Bar, United Kingdom.